Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
13.61Price to Sales
VS
Market
Sector
Industry
History
$ 2.2Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information
Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTSCAN THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TCRX - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 94.77M | 13.61 | $ 6.96M |
| 3/31/2025 | $ 76.96M | 17.41 | $ 4.42M |
| 12/31/2024 | $ 108.65M | 38.58 | $ 2.82M |
| 9/30/2024 | $ 289.27M | 30.9 | $ 9.36M |
| 6/30/2024 | $ 317.84M | 26.05 | $ 12.2M |
| 3/31/2024 | $ 423.43M | 28.59 | $ 14.81M |
| 12/31/2023 | $ 342.36M | 16.26 | $ 21.05M |
| 9/30/2023 | $ 206.12M | 12.17 | $ 16.93M |
| 6/30/2023 | $ 100.42M | 6.12 | $ 16.41M |
| 3/31/2023 | $ 117.5M | 6.79 | $ 17.32M |
Key Performance Insights, Last 5 Years
- TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, TSCAN THERAPEUTICS INC's average P/S has been 15.2.
- The median P/S for TSCAN THERAPEUTICS INC during this period was 12.17
- TSCAN THERAPEUTICS INC reached its highest P/S over the past 5 years at 38.58.
- The lowest P/S recorded by TSCAN THERAPEUTICS INC in the same timeframe 4.53
TSCAN THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for TSCAN THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 1.08M ]
(=) P/S [ 0 ] TCRX - Price to Sales, Last 5 years
4.53
Minimum
Mar 31, 2022
38.58
Maximum
Dec 31, 2024
15.2
Average
12.17
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |